Observational Study
Copyright ©The Author(s) 2023.
World J Gastroenterol. Dec 7, 2023; 29(45): 5962-5973
Published online Dec 7, 2023. doi: 10.3748/wjg.v29.i45.5962
Table 3 Subgroup analysis for the association between muscle strength and metabolic dysfunction-associated fatty liver disease

Muscle strength
OR (95%CI)
P for interaction
Sex0.126
    MenQ2–Q41 (reference)
Q12.05 (1.70–2.47)
    WomenQ2–Q41 (reference)
Q11.76 (1.47–2.10)
Age0.057
    < 65 yrQ2–Q41 (reference)
Q11.97 (1.70–2.29)
    ≥ 65 yrQ2–Q41 (reference)
Q11.74 (1.44–2.09)
Obesity0.264
    NoQ2–Q41 (reference)
Q11.63 (1.36–1.96)
    YesQ2–Q41 (reference)
Q12.09 (1.75–2.48)
Diabetes mellitus0.622
    NoQ2–Q41 (reference)
Q11.97 (1.72–2.26)
    YesQ2–Q41 (reference)
Q11.71 (1.33–2.22)